Stockreport

TransCode Therapeutics Open Letter to Shareholders

TransCode Therapeutics, Inc.  (RNAZ) 
PDF BOSTON, Nov. 12, 2024 (GLOBE NEWSWIRE) -- The Board and Management of TransCode Therapeutics (NASDAQ: RNAZ) today issued the following open letter to shareholders of t [Read more]